Leverage nVector’s advanced Adeno-Associated Virus platform to quick-launch your gene therapy strategy or accelerate existing initiatives. We enhance testing and trials with superior diagnostic biomarkers.
The nVector Platform – Next generation impact for CNS solutions
Gene therapy for CNS conditions promises great potential cures. But so far development has been slowed by lack of ability to target and access the right cells, and limited gene expression. Now, the nVector platform can help overcome those barriers.
Capsid Design Library
Identity and access the right viral capsid customized to your unique needs.
Developing treatments addressing ALS, Huntington’s and Parkinson’s and beyond.
Offering the first biologic diagnostic test for ALS.
Customized CNS biomarker testing and development.